Mission
ACCELERATE THE DISCOVERY OF DRUGS TO PREVENT, TREAT AND CURE ALZHEIMER'S DISEASE AND RELATED DEMENTIAS.
Based in NEW YORK, NY, ALZHEIMER'S DRUG DISCOVERY FOUNDATION operates as a Public Charity. The organization reported $82.2M in revenue, $47.6M in expenses, $315.5M in total assets for fiscal year 2025. Imperigo tracks 175 reported grant relationships connected to this organization totaling approximately $48.2M.
ACCELERATE THE DISCOVERY OF DRUGS TO PREVENT, TREAT AND CURE ALZHEIMER'S DISEASE AND RELATED DEMENTIAS.
How Alzheimer's Drug Discovery Foundation divides every $100 it spends, from its own Form 990 filings, averaged across 8 years.
Source: Form 990 filings with the IRS, latest fiscal year 2025. Shares are from the organization's reported expenses. Data by Imperigo; not affiliated with the IRS.
Showing up to 5 of 175 total records — full history available with membership.
Officer compensation and complete director data available with membership.
| Year | Revenue | Expenses | Assets |
|---|---|---|---|
| 2025 | $82.2M | $47.6M | $315.5M |
| 2024 | $47.3M | $88.3M | $299.4M |
| 2023 | $37.7M | $61.9M | $324.2M |
| 2022 | $254.0M | $36.8M | $340.3M |
| 2020 | $27.6M | $28.3M | $97.4M |
Between 2020 and 2025, reported annual revenue grew from $27.6M to $82.2M (+197%), with total assets most recently reported at $315.5M.
Interactive year-over-year charts and full filing details available with membership.